Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2 Kidney Neoplasms 2 Carcinoma, Renal Cell 2 Triple Negative Breast Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Solid Tumor 1 Rectal Neoplasms 1 Oligometastatic Prostate Cancer 1 Neoplasms 1 Metastatic Urothelial Cancer 1 Lung Diseases 1 Locally Advanced Cervical Cancer 1 Gestational Trophoblastic Disease 1 Gastro-enteropancreatic neuroendocrine tumor 1 Erythrocytosis, Familial, 4 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoid Tumor 1 Breast Neoplasms 1 Bile Duct Neoplasms 1 Advanced Solid Tumors 1 Advanced Solid Tumor 1

Interventions

Capecitabine 29 Oxaliplatin 28 Fluorouracil 16 Radiotherapy 15 Drug Therapy 11 Leucovorin 10 Bevacizumab 10 Surgical Procedures, Operative 9 Chemoradiotherapy 8 Radiation 7 sintilimab 6 Consolidation Chemotherapy 6 tislelizumab 5 spartalizumab 5 Specimen Handling 5 Irinotecan 5 Folfox protocol 5 trifluridine tipiracil drug combination 4 XELOX 4 Neoadjuvant Therapy 4 Endoscopy 4 Cetuximab 4 Biopsy 4 toripalimab 3 pembrolizumab 3 irinotecan sucrosofate 3 X-Rays 3 Radiotherapy, Intensity-Modulated 3 Proctectomy 3 Mastectomy, Segmental 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rectal Neoplasms × zimberelimab × Clear all

NCT05024097 2025-08-27

PANTHER

Weill Medical College of Cornell University

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡